Advertisement
Screener

PRECISION OPTICS CORPORATION, INC. (POCI) Net Income (Loss) Available to Common Stockholders, Basic

2.8 / 5 stars · 68/120 Roast Me

PRECISION OPTICS CORPORATION, INC. Net Income (Loss) Available to Common Stockholders, Basic

PRECISION OPTICS CORPORATION, INC. (POCI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$108.28 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-05-13

  • PRECISION OPTICS CORPORATION, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$108.28K.
  • PRECISION OPTICS CORPORATION, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$1.78M.
  • PRECISION OPTICS CORPORATION, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$1.64M.
  • PRECISION OPTICS CORPORATION, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was -$1.40M.
  • PRECISION OPTICS CORPORATION, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$5.78M.
  • PRECISION OPTICS CORPORATION, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$2.95M.
  • PRECISION OPTICS CORPORATION, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$144.61K.
  • PRECISION OPTICS CORPORATION, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$928.42K.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 3 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 6 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 9 month as first filedNet Income (Loss) Available to Common Stockholders, Basic 12 month
2026-03-31-$108.28K
10-Q · filed 2026-05-13
-$1.89M
derived: sum of 2 quarters · filed 2026-05-13
-$3.53M
10-Q · filed 2026-05-13
-$4.93M
derived: sum of 4 quarters · filed 2026-05-13
2025-12-31-$1.78M
10-Q · filed 2026-02-17
-$3.42M
10-Q · filed 2026-02-17
-$4.82M
derived: sum of 3 quarters · filed 2026-02-17
-$6.92M
derived: sum of 4 quarters · filed 2026-05-13
2025-09-30-$1.64M
10-Q · filed 2025-11-13
-$3.04M
derived: sum of 2 quarters · filed 2025-11-13
-$5.14M
derived: sum of 3 quarters · filed 2026-05-13
-$6.11M
derived: sum of 4 quarters · filed 2026-05-13
2025-06-30-$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29
-$3.50M
derived: sum of 2 quarters · filed 2026-05-13
-$4.47M
derived: sum of 3 quarters · filed 2026-05-13
-$5.78M
10-K · filed 2025-09-29
2025-03-31-$2.10M
10-Q · filed 2026-05-13
-$3.07M
derived: sum of 2 quarters · filed 2026-05-13
-$4.38M
10-Q · filed 2026-05-13
-$4.38M
10-Q · filed 2025-05-15
-$5.79M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$969.68K
10-Q · filed 2026-02-17
-$2.28M
10-Q · filed 2026-02-17
-$3.69M
derived: sum of 3 quarters · filed 2026-02-17
-$4.01M
derived: sum of 4 quarters · filed 2026-02-17
2024-09-30-$1.31M
10-Q · filed 2025-11-13
-$2.72M
derived: sum of 2 quarters · filed 2025-11-13
-$3.04M
derived: sum of 3 quarters · filed 2025-11-13
-$3.80M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$1.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29
-$1.73M
derived: sum of 2 quarters · filed 2025-09-29
-$2.49M
derived: sum of 3 quarters · filed 2025-09-29
-$2.95M
10-K · filed 2025-09-29
2024-03-31-$317.06K
10-Q · filed 2025-05-15
-$1.08M
derived: sum of 2 quarters · filed 2025-05-15
-$1.54M
10-Q · filed 2025-05-15
-$1.64M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$758.80K
10-Q · filed 2025-02-13
-$1.22M
10-Q · filed 2025-02-13
-$1.32M
derived: sum of 3 quarters · filed 2025-02-13
-$1.72M
derived: sum of 4 quarters · filed 2025-02-13
2023-09-30-$464.42K
10-Q · filed 2024-11-14
-$560.54K
derived: sum of 2 quarters · filed 2024-11-14
-$958.97K
derived: sum of 3 quarters · filed 2024-11-14
-$450.30K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$96.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30
-$494.56K
derived: sum of 2 quarters · filed 2024-09-30
$14.11K
derived: sum of 3 quarters · filed 2024-09-30
-$144.61K
10-K · filed 2024-09-30
2023-03-31-$398.43K
10-Q · filed 2024-05-15
$110.24K
derived: sum of 2 quarters · filed 2024-05-15
-$48.49K
10-Q · filed 2024-05-15
$220.81K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$508.67K
10-Q · filed 2024-02-14
$634.42K
10-Q · filed 2023-02-14
$349.94K
10-Q · filed 2024-02-14
$560.91K
10-Q · filed 2023-02-14
$619.24K
derived: sum of 3 quarters · filed 2024-02-14
$505.34K
derived: sum of 4 quarters · filed 2024-02-14
2022-09-30-$158.72K
10-Q · filed 2023-11-14
-$73.51K
10-Q · filed 2022-11-14
$110.57K
derived: sum of 2 quarters · filed 2023-11-14
-$3.33K
derived: sum of 3 quarters · filed 2023-11-14
-$510.34K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$269.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
$155.40K
derived: sum of 2 quarters · filed 2023-09-28
-$351.62K
derived: sum of 3 quarters · filed 2023-09-28
-$928.42K
10-K · filed 2023-09-28
2022-03-31-$113.90K
10-Q · filed 2023-05-15
-$620.91K
derived: sum of 2 quarters · filed 2023-05-15
-$1.20M
10-Q · filed 2023-05-15
-$1.64M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$507.01K
10-Q · filed 2023-02-14
-$1.08M
10-Q · filed 2023-02-14
-$1.53M
derived: sum of 3 quarters · filed 2023-02-14
-$973.99K
derived: sum of 4 quarters · filed 2023-02-14
2021-09-30-$576.80K
10-Q · filed 2022-11-14
-$1.02M
derived: sum of 2 quarters · filed 2022-11-14
-$466.98K
derived: sum of 3 quarters · filed 2022-11-14
-$680.43K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$442.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27
$109.83K
derived: sum of 2 quarters · filed 2022-09-27
-$103.63K
derived: sum of 3 quarters · filed 2022-09-27
-$102.83K
10-K · filed 2022-09-27
2021-03-31$552.28K
10-Q · filed 2022-05-16
$338.82K
derived: sum of 2 quarters · filed 2022-05-16
$339.62K
10-Q · filed 2022-05-16
2020-12-31-$213.45K
10-Q · filed 2022-02-14
-$212.66K
10-Q · filed 2022-02-14
2013-06-30-$173.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30
-$523.10K
derived: sum of 2 quarters · filed 2013-09-30
-$1.43M
derived: sum of 3 quarters · filed 2013-09-30
-$1.79M
10-K · filed 2013-09-30
2013-03-31-$349.99K
10-Q · filed 2013-05-15
-$1.26M
derived: sum of 2 quarters · filed 2013-05-15
-$1.61M
10-Q · filed 2013-05-15
-$1.84M
derived: sum of 4 quarters · filed 2013-09-30
2012-12-31-$906.48K
10-Q/A · filed 2013-02-15
-$1.26M
10-Q/A · filed 2013-02-15
-$1.49M
derived: sum of 3 quarters · filed 2013-09-30
-$1.98M
derived: sum of 4 quarters · filed 2013-09-30
2012-09-30-$358.09K
10-Q · filed 2012-11-14
-$578.55K
derived: sum of 2 quarters · filed 2013-09-30
-$1.07M
derived: sum of 3 quarters · filed 2013-09-30
-$1.40M
derived: sum of 4 quarters · filed 2013-09-30
2012-06-30-$220.46K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30
-$712.59K
derived: sum of 2 quarters · filed 2013-09-30
-$1.04M
derived: sum of 3 quarters · filed 2013-09-30
$960.97K
10-K · filed 2013-09-30
2012-03-31-$492.14K
10-Q · filed 2013-05-15
-$817.01K
derived: sum of 2 quarters · filed 2013-05-15
$1.18M
10-Q · filed 2013-05-15
2011-12-31-$324.88K
10-Q/A · filed 2013-02-15
$1.67M
10-Q/A · filed 2013-02-15
2011-09-30$2.00M
10-Q · filed 2012-11-14
2011-06-30-$1.05M
10-K/A · filed 2012-10-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outset Medical, Inc. (OM)United States$0.059B-1.09
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
Streamex Corp. (STEX)United States$0.089B-0.19
IRIDEX CORP (IRIX)United States$0.011B
Nexalin Technology, Inc. (NXL)United States$0.094B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Neuraxis, INC (NRXS)United States$0.097B
Nuwellis, Inc. (NUWE)United States$0.003B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B